Tenax Therapeutics Inc. (NASDAQ: TENX) started the day on November 23, 2022, with a price increase of 11.29% at $0.14. During the day, the stock rose to $0.1398 and sunk to $0.1201 before settling in for the price of $0.12 at the close. Taking a more long-term approach, TENX posted a 52-week range of $0.08-$1.46.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
Meanwhile, its Annual Earning per share during the time was 44.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -20.70%. This publicly-traded company’s shares outstanding now amounts to $44.70 million, simultaneously with a float of $35.57 million. The organization now has a market capitalization sitting at $4.91 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1521, while the 200-day Moving Average is $0.4163.
Tenax Therapeutics Inc. (TENX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Tenax Therapeutics Inc.’s current insider ownership accounts for 10.50%, in contrast to 16.30% institutional ownership.
Tenax Therapeutics Inc. (TENX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 6/29/2022, the organization reported -$0.11 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.09) by -$0.02. This company achieved a return on equity of -732.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
Tenax Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -20.70% and is forecasted to reach -0.13 in the upcoming year.
Tenax Therapeutics Inc. (NASDAQ: TENX) Trading Performance Indicators
Let’s observe the current performance indicators for Tenax Therapeutics Inc. (TENX). It’s Quick Ratio in the last reported quarter now stands at 6.50. The Stock has managed to achieve an average true range (ATR) of 0.03.
In the same vein, TENX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.48, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.13 at the market close of one year from today.
Technical Analysis of Tenax Therapeutics Inc. (TENX)
If we take a close look at the recent performances of Tenax Therapeutics Inc. (NASDAQ: TENX), its last 5-days Average volume was 8.62 million that shows progress from its year to date volume of 1.26 million. During the previous 9 days, stock’s Stochastic %D was recorded 41.41% While, its Average True Range was 0.0288.